{"url":"https://lda.senate.gov/api/v1/filings/cf66dd7b-4193-4c3b-aad9-e8ec94cfa540/","filing_uuid":"cf66dd7b-4193-4c3b-aad9-e8ec94cfa540","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2017,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/cf66dd7b-4193-4c3b-aad9-e8ec94cfa540/print/","filing_document_content_type":"text/html","income":null,"expenses":"150000.00","expenses_method":"a","expenses_method_display":"Method A - Reporting amounts using LDA definitions only","posted_by_name":"Lance Gilgore","dt_posted":"2017-07-18T23:39:05.707000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1825 K Street NW, Suite 425","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":316731,"url":"https://lda.senate.gov/api/v1/registrants/316731/","house_registrant_id":39286,"name":"DAIICHI SANKYO, INC.","description":null,"address_1":"211 Mt Airy Rd","address_2":null,"address_3":null,"address_4":null,"city":"Basking Ridge","state":"NJ","state_display":"New Jersey","zip":"07920","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"AMANDA PEZALLA","contact_telephone":"+1 202-223-6572","dt_updated":"2026-07-29T22:42:31.603206-04:00"},"client":{"id":185884,"url":"https://lda.senate.gov/api/v1/clients/185884/","client_id":12,"name":"DAIICHI SANKYO INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-13"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Discussions regarding the Affordable Health Care Act (ACA)\nH.R.1703, Medical Product Communications Act of 2017","foreign_entity_issues":"To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.","lobbyists":[{"lobbyist":{"id":6903,"prefix":null,"prefix_display":null,"first_name":"LANCE","nickname":null,"middle_name":null,"last_name":"GILGORE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Discussions regarding Medicare","foreign_entity_issues":"To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.","lobbyists":[{"lobbyist":{"id":6903,"prefix":null,"prefix_display":null,"first_name":"LANCE","nickname":null,"middle_name":null,"last_name":"GILGORE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"H.R.2025, Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017\nH.R.2430 and S.934, FDA Reauthorization Act of 2017","foreign_entity_issues":"To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.","lobbyists":[{"lobbyist":{"id":6903,"prefix":null,"prefix_display":null,"first_name":"LANCE","nickname":null,"middle_name":null,"last_name":"GILGORE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}